TEFCA scale, BCDA v3, and electronic prior-authorization momentum are changing interoperability from a compliance feature into a distribution and implementation advantage for healthcare companies.
Return to insightsHealthcare AI founders, payer and provider platforms, product leaders, implementation teams, and investors / 2026-07-19
Founder question
All network and API milestones are attributed to HHS or CMS. Commercial implications are independent operator analysis.
Executive thesis
Interoperability becomes strategically valuable when it reduces the cost of entering a workflow. National exchange, bulk claims APIs, and electronic authorization standards can shorten the distance between contract and live value, but only if the company has a clear data contract, reconciliation model, accountable action, and proof loop. Data liquidity is not the product. It is the distribution rail for a product that knows what to do next.
HHS reported in February 2026 that nearly 500 million health records had been exchanged through TEFCA, up from roughly 10 million in January 2025.
CMS made BCDA v3 available on July 1, 2026 and set July 30, 2027 as the removal date for access to v1 and v2, giving ACOs a defined migration window for bulk claims data.
CMS announced 29 early-adopter organizations working on electronic prior authorization ahead of 2027 requirements.
The commercial advantage is faster implementation and broader reach, not the existence of an API connection.
Standards reduce transport friction but do not eliminate semantic, identity, attribution, workflow, or exception work. Those operating layers remain differentiators.
Products that can convert network data into a reconciled object, a bounded action, and auditable proof will scale more cleanly than products that simply aggregate feeds.
Migration events such as BCDA v3 are commercial moments because they force buyers to revisit data architecture, vendor capability, and implementation ownership.
Operating model
The framework defines the work; the metrics define whether the work is creating value.
Map the minimum data needed for the buyer decision and the authoritative source for each element.
Use network and API access to shorten implementation, not to collect data without a clear workflow purpose.
Translate data into an owned work object, accountable action, and measurable outcome.
Design identity, consent, provenance, reconciliation, and exception controls before expanding data volume.
Measure the commercial advantage in launch time, workflow completion, and retained value.
Contract-to-live implementation time
Data completeness and reconciliation rate
Time from data availability to accountable action
Manual integration and exception burden
Expansion enabled by reusable connectors and data contracts
Founders should treat interoperability as part of distribution and onboarding strategy.
Buyers should ask how the product resolves conflicting sources and what work happens after ingestion.
Implementation teams should productize mappings, validation, and exception handling rather than rediscovering them for every customer.
Choose one buyer workflow and write the data-to-action contract.
Inventory reusable FHIR, TEFCA, claims, and authorization capabilities.
Instrument data quality, reconciliation, exception handling, and launch time.
Sell the reduced implementation burden and operating result, not standards compliance alone.
The roadmap celebrates data access but cannot name the decision it changes.
Each customer still requires a bespoke semantic and workflow implementation.
The company cannot explain provenance, identity, or reconciliation when sources disagree.
Which implementation bottleneck disappears if this data is available through a standard path?
Who acts on the data and in which system?
How are provenance and conflicting records handled?
What reusable asset remains after the first integration?
Design the data, workflow, implementation, and proof architecture that converts interoperability into faster value.
Turn data access into distributionStart a serious conversation